Reuters logo
BRIEF-Nivalis Therapeutics reports Q3 loss per share $0.48
November 7, 2016 / 9:27 PM / a year ago

BRIEF-Nivalis Therapeutics reports Q3 loss per share $0.48

Nov 7 (Reuters) - Nivalis Therapeutics Inc -

* Nivalis Therapeutics reports third quarter 2016 financial results

* Q3 loss per share $0.48

* Q3 earnings per share view $-0.59 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below